日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

Novo Nordisk sees ample room for further expansion in nation

By LIU ZHIHUA | China Daily | Updated: 2021-06-08 09:14
Share
Share - WeChat
Employees work on the production line of a Novo Nordisk venture in Tianjin. [Provided to China Daily]

China's sustained efforts to improve the business environment and encourage innovation will boost its long-term growth prospects and create ample expansion opportunities for foreign businesses, according to a senior pharmaceutical company official.

Lars Fruergaard Jorgensen, president and CEO of Denmark-based biopharmaceutical company Novo Nordisk, said he was confident about long-term growth in the country.

"We are fully confident that the Chinese economy will maintain growth. The 14th Five-Year Plan (2021-25) will serve as a roadmap for economic and social development and help sustain high-quality growth. With a supportive business environment, we are confident that Novo Nordisk, along with other foreign businesses, will enjoy long-term success in the country."

Novo Nordisk, a global leader in diabetes care, will continue to invest in a sustainable and innovation-based healthcare ecosystem in China, he said.

As China enters a new development phase featuring the dual-circulation development paradigm, which takes the domestic market as the mainstay while letting domestic and foreign markets reinforce each other, there will be significant opportunities for the company to continue enhancing its presence across the whole value chain and strengthen innovation and production capabilities to fulfill the growing needs of people with diabetes in China and globally, said Jorgensen.

China's strong economic recovery since COVID-19 is impressive, said Jorgensen, adding that Novo Nordisk's unit in the country gained significantly due to the robust domestic demand.

China has been leaving no stone unturned to deepen reforms, pursue higher-level opening-up and improve business environment, as part of its broader push to ensure high-quality development. Thanks to its robust economic performance and continuously improving business environment, foreign investors' enthusiasm in the country has been increasing steadily, experts said.

According to a recent survey conducted by the Ministry of Commerce, 96.4 percent of the more than 3,200 surveyed foreign-invested companies had a positive attitude toward future business prospects in China, up 2.1 percentage points from the beginning of this year.

Data from the ministry showed that China's actual use of foreign investment during the January-April period rose 38.6 percent on a yearly basis to 397.07 billion yuan ($62.27 billion). The total FDI value grew by 30.1 percent over the same period in 2019.

In the healthcare sector, a series of major policy reforms have been introduced since 2015, to encourage innovation, speed up new drug registration, and enhance the dynamic adjustment mechanism for the national reimbursement drug list, so as to improve quality healthcare accessibility and affordability.

According to the 14th Five-Year Plan and long-range objectives through 2035, China will continue to improve the fast-track review and approval mechanism for innovative medicines, vaccines and medical devices, so as to accelerate review and approval of medicines and medical devices for urgent clinical use and rare disease treatment.

Novo Nordisk has already established a full value chain in the country, with one of its biggest manufacturing bases in Tianjin that supplies both Chinese and international markets with durable devices for insulin injection and insulin products.

With its China Essentials program launched and updated in 2020, the company has integrated China into its latest global clinical development, aiming to achieve simultaneous submission for global new drug applications in the country.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 精品伊人久久久大香线蕉欧美 | 污视频在线免费 | 国产福利视频 | 欧美日韩欧美日韩 | chinese 军人 gay xx 呻吟 | 激情成人综合网 | 成人福利 | 亚洲aⅴ| 精品欧美日韩 | 精品国产日韩一区三区 | 污污的网站免费观看 | 日韩欧美不卡在线 | 欧美日本免费一区二区三区 | 国产亚洲精品久久一区二区三区 | 波多野结衣一区二区三区在线观看 | 日本三级全黄 | 国产网址在线观看 | 成人午夜AV亚洲精品无码网站 | 国产精品网址你懂的 | 荷兰欧美一级毛片 | 91精品电影 | 天天做夜夜操 | avbobo在线 | 色呦呦免费 | 91精选国产91在线观看 | 成人一区二区三区 | 亚洲高清中文字幕一区二区三区 | 激情se| 久久男人 | 久久一本日韩精品中文字幕屁孩 | 男人天堂av网站 | 羞羞的动漫在线观看 | 久久亚洲精品国产精品黑人 | 日本高清不卡一区久久精品 | 国产激情一级毛片久久久 | 亚洲网站在线观看 | 色综合啪啪| 国产精品免费视频网站 | 成人网免费视频 | 精品a级片 | 男人添女人下面免费网站 |